Patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastases.


Journal

Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 04 06 2019
revised: 18 07 2019
accepted: 26 07 2019
pubmed: 7 9 2019
medline: 4 6 2020
entrez: 7 9 2019
Statut: ppublish

Résumé

Patient satisfaction is infrequently investigated despite its importance in assessing efficacy and patient comprehension. The purpose of this study was to investigate patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastases and to evaluate how health-related quality of life (HRQOL) is related to patient satisfaction. Patients with spinal metastases treated with surgery and/or radiotherapy were enrolled in a prospective, international, observational study. Demographic, histologic, treatment, and HRQOL data were collected. HRQOL was evaluated with the Numeric Rating Scale pain score, the 3-level version of the EuroQol 5-Dimension (EQ-5D-3L) instrument, and the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0). Patient satisfaction was derived from the SOSGOQ2.0 at 6, 12, and 26 weeks after treatment. Patients were classified as satisfied, neutral, or dissatisfied. Twelve weeks after treatment, 183 of the surgically treated patients (84%) were satisfied, and only 11 (5%) were dissatisfied; in contrast, 101 of the patients treated with radiotherapy alone (77%) were satisfied, and only 7 (5%) were dissatisfied. Significant improvements in pain, physical function, mental health, social function, leg function, and EQ-5D were associated with satisfaction after surgery. Satisfaction after radiotherapy was associated with significant improvements in pain, mental health, and overall SOSGOQ2.0 scores. Dissatisfaction after treatment was associated with lower baseline values for leg strength and lower social functioning scores for surgically treated patients and with lower social functioning scores and being single for patients treated with radiotherapy. High levels of satisfaction with treatment outcomes are observed after surgery and/or radiotherapy for spinal metastases. Posttreatment satisfaction is associated with significant improvements in pain and different dimensions of HRQOL.

Sections du résumé

BACKGROUND
Patient satisfaction is infrequently investigated despite its importance in assessing efficacy and patient comprehension. The purpose of this study was to investigate patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastases and to evaluate how health-related quality of life (HRQOL) is related to patient satisfaction.
METHODS
Patients with spinal metastases treated with surgery and/or radiotherapy were enrolled in a prospective, international, observational study. Demographic, histologic, treatment, and HRQOL data were collected. HRQOL was evaluated with the Numeric Rating Scale pain score, the 3-level version of the EuroQol 5-Dimension (EQ-5D-3L) instrument, and the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0). Patient satisfaction was derived from the SOSGOQ2.0 at 6, 12, and 26 weeks after treatment. Patients were classified as satisfied, neutral, or dissatisfied.
RESULTS
Twelve weeks after treatment, 183 of the surgically treated patients (84%) were satisfied, and only 11 (5%) were dissatisfied; in contrast, 101 of the patients treated with radiotherapy alone (77%) were satisfied, and only 7 (5%) were dissatisfied. Significant improvements in pain, physical function, mental health, social function, leg function, and EQ-5D were associated with satisfaction after surgery. Satisfaction after radiotherapy was associated with significant improvements in pain, mental health, and overall SOSGOQ2.0 scores. Dissatisfaction after treatment was associated with lower baseline values for leg strength and lower social functioning scores for surgically treated patients and with lower social functioning scores and being single for patients treated with radiotherapy.
CONCLUSIONS
High levels of satisfaction with treatment outcomes are observed after surgery and/or radiotherapy for spinal metastases. Posttreatment satisfaction is associated with significant improvements in pain and different dimensions of HRQOL.

Identifiants

pubmed: 31490548
doi: 10.1002/cncr.32465
pmc: PMC6900159
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4269-4277

Subventions

Organisme : AOSpine
Pays : International
Organisme : Orthopaedic Research and Education Foundation
Pays : International
Organisme : NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : AOSpine International
Pays : International

Informations de copyright

© 2019 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society.

Références

Clin Oncol (R Coll Radiol). 2012 Mar;24(2):112-24
pubmed: 22130630
Arch Surg. 2011 May;146(5):517-22
pubmed: 21576604
Spine (Phila Pa 1976). 2017 May 15;42(10):764-769
pubmed: 27748701
J Radiat Oncol. 2018;7(1):17-26
pubmed: 29576859
Spine J. 2010 Jan;10(1):42-9
pubmed: 19665939
BMC Cancer. 2014 Jan 25;14:42
pubmed: 24460858
Urology. 2006 Dec;68(6):1224-9
pubmed: 17141840
J Bone Joint Surg Am. 2015 Jan 7;97(1):80-4
pubmed: 25568398
Soc Sci Med. 1997 Dec;45(12):1829-43
pubmed: 9447632
Spine (Phila Pa 1976). 2006 Nov 15;31(24):2849-56
pubmed: 17108840
Neurosurgery. 2018 May 1;82(5):645-651
pubmed: 28575297
J Neurosurg Spine. 2014 Nov;21(5):698-703
pubmed: 25147976
Cancer. 2018 Apr 15;124(8):1828-1838
pubmed: 29409108
Orthopedics. 2013 Nov;36(11):e1424-30
pubmed: 24200448
Health Qual Life Outcomes. 2013 Mar 14;11:46
pubmed: 23497387
N Engl J Med. 2008 Jul 10;359(2):200-1; author reply 201-2
pubmed: 18618944
Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S128-34
pubmed: 19829272
J Clin Oncol. 2016 Jan 20;34(3):268-76
pubmed: 26598751

Auteurs

Anne L Versteeg (AL)

Department of Orthopedics, University Medical Center Utrecht, Utrecht, the Netherlands.

Arjun Sahgal (A)

Department of Radiation Oncology, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

Norio Kawahara (N)

Department of Orthopedic Surgery, Kanazawa Medical University Hospital, Kanazawa, Japan.

Laurence D Rhines (LD)

Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Daniel M Sciubba (DM)

Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Michael H Weber (MH)

Division of Surgery, McGill University and Montreal General Hospital, Montreal, Quebec, Canada.

Áron Lazary (Á)

National Center for Spinal Disorders, Buda Health Center, Budapest, Hungary.

Michael G Fehlings (MG)

Division of Neurosurgery and Spine Program, University of Toronto and Toronto Western Hospital, Toronto, Ontario, Canada.

James M Schuster (JM)

Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Michelle J Clarke (MJ)

Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota.

Paul M Arnold (PM)

Department of Neurosurgery, University of Kansas Hospital, Kansas City, Kansas.

Stefano Boriani (S)

Institutes for Care and Scientific Research (IRCCS) Galeazzi Orthopedic Hospital, Milan, Italy.

Chetan Bettegowda (C)

Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ziya L Gokaslan (ZL)

Department of Neurosurgery, Warren Alpert Medical School of Brown University, Rhode Island Hospital, and Miriam Hospital, Providence, Rhode Island.

Charles G Fisher (CG)

Division of Spine Surgery, Department of Orthopaedics, University of British Columbia and Vancouver General Hospital, Vancouver, British Columbia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH